Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Premier Laser/Ophthalmic Imaging Systems

This article was originally published in The Gray Sheet

Executive Summary

Premier would acquire the 49% of ophthalmic digital imaging system maker OIS that it does not currently own under an agreement announced Oct. 22. While OIS had previously rejected as inadequate a Premier offer of $0.85 worth of Premier stock for each OIS share, the revised agreement would provide roughly $1.78 per share. OIS shareholders, which have yet to approve the pact, would receive 0.8 shares of Premier common stock per OIS share; Premier closed at 2-7/32 the day before the announcement. The two firms had first planned to merge under a February 1998 agreement, which was subsequently dissolved (1"The Gray Sheet" June 28, p. 21)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012525

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel